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MATERIALS AND METHODS
Mice. Female 6-to 8-wk-old C57BL/6J wild-type and ␤2-microglobulin knockout (␤2MKO, strain B6.129P-B2m tm1Unc ) mice were purchased from Jackson Laboratory (Bar Harbor, ME). Selective depletion of NK cells was performed by injection of anti-asialoGM1 (50 g ip; Cedarlane Laboratories, Hornby, Ontario, Canada) 24 h before CLP (19) . All studies were approved by the Institutional Animal Care and Use Committee at the University of Texas Medical Branch and met National Institutes of Health guidelines for the care and use of experimental animals.
CLP. Mice were anesthetized with 2% isoflurane in oxygen via a facemask. A 1-to 2-cm midline incision was made through the abdominal wall; the cecum was identified and ligated with a 3-0 silk tie 1 cm from the tip. Care was taken not to cause bowel obstruction. A single puncture of the cecal wall was performed with a 20-gauge needle. The cecum was lightly squeezed to express a small amount of stool from the puncture site to assure a full-thickness perforation. Great care was taken to preserve continuity of flow between the small and large bowels. Inspection of mice at various intervals after CLP did not reveal evidence of bowel obstruction. The cecum was returned to the abdominal cavity, and the incision was closed with surgiclips. Mice were presented to the surgeon in a blinded fashion to minimize experimental bias. Sham mice underwent anesthesia and midline laparotomy; the cecum was exteriorized and returned to the abdomen, and the wound was closed with surgiclips. Mice received intraperitoneal injection of imipenem-cilistatin (25 mg/kg Primaxin; Merck, Whitehouse Station, NJ) in 1 ml normal saline beginning immediately after CLP and every 8 h thereafter. Control mice received 1 ml normal saline in the same regimen. Measurement of arterial blood gases, temperature, cytokine levels, and bacterial colony counts was performed at 18 h after CLP. The 18-h time point was chosen because wild-type mice exhibit significant morbidity at that time, and mortality begins at 20 -24 h after CLP in the wild-type group.
ELISA. Peritoneal fluid was harvested from mice by lavage of the peritoneal cavity with 5 ml sterile saline, and heparinized blood was obtained by carotid laceration in mice anesthetized with 2% isoflurane. Plasma was harvested by centrifuging blood (1,200 g for 10 min). Interleukin-6 (IL-6), macrophage inflammatory protein-2 (MIP-2) and keratinocyte-derived chemokine (KC) concentrations in peritoneal fluid and plasma were determined using an ELISA according to the manufacturer's protocol (eBioscience, San Diego, CA). Briefly, standards or experimental samples were added to microtiter plates that were coated with capture antibodies to the cytokine of interest and incubated for 2 h. After washing, horseradish peroxidaseconjugated, cytokine-specific antibody was added to each well, incubated for 2 h, and washed. Substrate solution was added and incubated for 30 min, and the reaction was terminated by the addition of stop solution. Cytokine levels were determined by measuring optical density at 450 nm using a microtiter plate reader (Dynatech Laboratories, Chantilly, VA).
Measurement of temperature and arterial blood gases. Body temperature was measured by insertion of a rectal temperature probe before induction of anesthesia with 1.5-2.5% isoflurane in 100% oxygen via a facemask. After induction of anesthesia, arterial blood for blood gas measurements was obtained by laceration of the carotid artery under direct visualization using a surgical microscope. Blood was harvested using heparinized syringes, and blood gas measurements were performed using iStat cartridges (iStat, East Windsor, NJ).
Microbiology. Bacterial counts were performed on aseptically harvested blood and peritoneal fluid. All fluid and tissue harvesting was performed under 2% isoflurane anesthesia. Blood was obtained by carotid laceration after aseptic preparation of the neck. Peritoneal fluid was harvested by an injection of 5 ml sterile saline in the peritoneal cavity after aseptic preparation of the abdominal wall followed by aspiration of peritoneal fluid. Samples were serially diluted in sterile saline and cultured on tryptic soy agar pour plates. Plates were incubated (37°C) for 48 -72 h, and colony counts were performed. Anaerobic conditions were achieved using an anaerobic chamber and the BBL GasPak Plus Anaerobic system (Becton-Dickinson, Sparks, MD). Endotoxin concentrations in plasma and peritoneal fluid were measured using a Limulus Amoebocyte Lysate assay (Cambrex BioScience, Walkersville, MD).
Statistics. All data were analyzed using GraphPad Prism software (GraphPad Software, San Diego, CA). Survival curves were compared using the log rank test. For temperature, acid-base, cytokine, and endotoxin measurements, means Ϯ SE were calculated. Data from multiple group experiments were analyzed using one-way ANOVA followed by a post hoc Tukey test to compare groups. In studies in which two groups were compared, a nonpaired Student's t-test was performed. For measurements of bacterial colony-forming units (CFU), all data points are presented, and the median was determined. Groups were compared using a nonparametric Kruskal-Wallis test followed by a post hoc Dunn's test. A value of P Ͻ 0.05 was considered statistically significant for all experiments.
RESULTS

Effect of imipenem treatment on bacterial counts and endotoxin concentrations in blood and peritoneal fluid following CLP.
The numbers of aerobic and anaerobic bacteria in blood and peritoneal fluid were measured at 18 h after CLP in wild-type and ␤2MKO/␣AsGM1 mice ( Fig. 1) . Imipenem treatment decreased the number aerobic bacteria in blood and peritoneal fluid by at least two orders of magnitude in both wild-type and ␤2MKO/␣AsGM1 mice. Treatment of wild-type and ␤2MKO/␣AsGM1 mice with imipenem eliminated anaerobes from blood and decreased counts of anaerobic bacteria in peritoneal fluid by more than two orders of magnitude.
Endotoxin concentrations in plasma and peritoneal fluid were also measured at 18 h after CLP in wild-type and ␤2MKO/␣AsGM1 mice (Fig. 2) . Imipenem treatment did not significantly change endotoxin concentrations in plasma or peritoneal fluid from wild-type or ␤2MKO/␣AsGM1 mice.
Effect of imipenem treatment on survival in wild-type and ␤2MKO/␣AsGM1 mice after CLP. Mice underwent CLP and were treated with either saline or imipenem. Survival was monitored for 2 wk after CLP (Fig. 3) . Wild-type mice treated with either saline or imipenem exhibited median survival times of 24 h and 100% mortality by 42 h after CLP. Survival rates were not significantly different between these groups. Salinetreated ␤2MKO/␣AsGM1 mice showed 40% survival after CLP, which was significantly (P Ͻ 0.05) improved compared with both wild-type groups. Treatment of ␤2MKO/␣AsGM1 mice with imipenem improved survival to 90%. Imipenemtreated ␤2MKO/␣AsGM1 mice had a significantly (P Ͻ 0.05) higher survival rate compared with saline-treated ␤2MKO/ ␣AsGM1 mice and also had significantly improved survival compared with mice in both wild-type groups. All ␤2MKO/ ␣AsGM1 mice that survived to 120 h after CLP were alive at 2 wk after CLP without evidence of ongoing morbidity.
Effect of imipenem treatment on temperature and acid-base balance in wild-type and ␤2MKO/␣AsGM1 mice. Core body temperature and arterial blood gases were measured at 18 h after CLP in wild-type and ␤2MKO/␣AsGM1 mice that received saline or imipenem treatment (Fig. 4) . Wild-type mice treated with saline or imipenem had significant hypothermia and acidosis compared with sham mice. The acidosis was primarily metabolic, as indicated by significantly decreased blood bicarbonate concentrations and increased base deficits in saline-and imipenemtreated wild-type mice compared with sham mice (Fig. 4) . Temperature and acid-base balance were not significantly different between saline and imipenem-treated wild-type mice at 18 h after CLP. CLP-induced hypothermia and metabolic acidosis were significantly attenuated in ␤2MKO/␣AsGM1 mice compared with wild-type mice. Temperature and the measured acid-base parameters were not significantly different when comparing saline-and imipenem-treated ␤2MKO/␣AsGM1 mice (Fig. 4) .
Effect of imipenem treatment on cytokine concentrations in wild-type and ␤2MKO/␣AsGM1 mice at 18 h after CLP.
Concentrations of IL-6, MIP-2, and KC in plasma and peritoneal fluid were measured at 18 h after CLP in wild-type and ␤2MKO/␣AsGM1 mice (Table 1) . Wild-type mice had high levels of IL-6, MIP-2, and KC in plasma and peritoneal fluid at 18 h after CLP. Concentrations of IL-6, MIP-2, and KC in plasma and peritoneal fluid were significantly lower in ␤2MKO/␣AsGM1 mice compared with wild-type mice. Imipenem treatment did not significantly change concentrations of IL-6, MIP-2, or KC in plasma or peritoneal fluid in wild-type or ␤2MKO/␣AsGM1 mice at 18 h after CLP.
Effect of imipenem treatment on temperature, acid-base balance, and cytokine production at 36 h after CLP in ␤2MKO/␣AsGM1 mice. Results of the present study showed that imipenem treatment improves survival in ␤2MKO/ ␣AsGM1 mice. However, differences in rectal temperature, acid-base balance, and cytokine production were not observed at 18 h after CLP when saline-and imipenem-treated ␤2MKO/ ␣AsGM1 mice were compared. Therefore, studies were undertaken to assess these parameters at 36 h after CLP. Salinetreated ␤2MKO/␣AsGM1 mice had Ͼ10 5 aerobic and anaerobic bacterial CFU in blood and peritoneal fluid at 36 h after CLP (Fig. 5) . Aerobic bacteria were not detectable in blood or peritoneal fluid of imipenem-treated ␤2MKO/␣AsGM1 mice at 36 h after CLP, and only one of six cultures from blood and peritoneal fluid had detectable anaerobic bacteria. Plasma endotoxin concentrations were not significantly different between saline-and imipenem-treated ␤2MKO/␣AsGM1 mice at 36 h after CLP (Fig. 6 ). Rectal temperature, blood pH, and blood bicarbonate concentrations were significantly decreased in saline-treated ␤2MKO/ ␣AsGM1 mice compared with those treated with imipenem ( Fig.  7) . Base deficit was significantly increased in saline-treated ␤2MKO/␣AsGM1 mice compared with imipenem-treated ␤2MKO/␣AsGM1 mice at 36 h after CLP. Plasma and peritoneal fluid concentrations of IL-6 and MIP-2 were significantly lower in imipenem-treated ␤2MKO/␣AsGM1 mice compared with salinetreated mice at 36 h after CLP (Fig. 8) . Values represent the means Ϯ SE; n ϭ 5-7 mice/group. IL-6, interleukin-6; MIP-2, macrophage inhibitory 2; KC, keratinocyte-derived chemokine; CLP, cecal ligation and puncture. Plasma and peritoneal fluid were harvested at 18 h after CLP. Cytokine concentrations were measured using an ELISA. *Significantly (P Ͻ 0.05) less than saline-treated wild-type mice.
DISCUSSION
The present study clearly demonstrates high bacterial counts in blood and peritoneal fluid from non-antibiotic-treated mice after CLP. This finding is consistent with numerous other reports that have shown bacterial dissemination in mice after CLP (2, 18, 34) . One goal of our study was to determine whether systemic infection is a major cause of injury and mortality in wild-type mice after CLP. Results of this study show that treatment of wild-type mice with imipenem, a broad-spectrum antibiotic, does not improve survival despite decreasing bacterial burden in blood and peritoneal fluid by more than two orders of magnitude. This observation suggests that systemic infection is not the primary cause of mortality for wild-type mice in our model of CLP. Other investigators have also examined the effect of antibiotic treatment on inflammation and mortality in mice after CLP (2, 28, 30, 32, 33) . Most prior studies show only limited improvement in survival after antibiotic treatment despite marked decreases in bacterial burden. Taken together, these studies indicate that bacterial dissemination is not the only factor contributing to CLP-induced morbidity and mortality.
We also hypothesized that ␤2MKO/␣AsGM1 mice are resistant to the infectious component of CLP. ␤2MKO/␣AsGM1 mice that did not receive imipenem treatment had improved survival after CLP compared with wild-type mice. Salinetreated ␤2MKO/␣AsGM1 mice that died after CLP also had a delayed mortality pattern compared with wild-type mice. Treatment of ␤2MKO/␣AsGM1 mice with imipenem conferred near-complete resistance to CLP-induced mortality. One interpretation of these findings is that ␤2MKO/␣AsGM1 mice are resistant to early, non-infection-related mechanisms of CLP-induced injury but eventually succumb to bacterial dissemination. Treatment of ␤2MKO/␣AsGM1 mice with imipenem appears to eliminate infection as a mechanism of injury and provides near-complete resistance to CLP-induced mortality in these mice. These findings suggest that early injury in our model of CLP is caused by non-infection-related mechanisms. Other potential mechanisms of CLP-induced injury include cecal ischemia and dissemination of bacterial products such as endotoxin and superantigens. There is a high probability that these early mechanisms of injury are mediated or facilitated by CD8 ϩ T and NK cells, because our previous studies showed that depletion of CD8 ϩ T and NK cells is the primary alteration conferring the resistance of ␤2MKO/␣AsGM1 mice to CLPinduced injury (18, 26) . Mice, such as ␤2MKO/␣AsGM1 mice, which are resistant to these early mechanisms of CLP-induced injury, appear susceptible to infection-associated morbidity and mortality. Treatment of ␤2MKO/␣AsGM1 mice with imipenem removed infection as a source of injury and markedly improved long-term survival in ␤2MKO/␣AsGM1 mice after CLP.
In the present study, the full length of the cecum was ligated. Great care was taken to prevent small bowel obstruction, and postmortem examination did not reveal evidence of bowel obstruction in any mice used in this investigation. Ligation of A and B) and anaerobic bacterial colony counts (C and D) were performed on serially diluted samples using tryptic soy agar plates. Ratios indicate the numbers of mice with positive cultures as a proportion of total mice in each group. The median bacterial count is designated for each group. *Significantly (P Ͻ 0.05) less than saline-treated mice. Fig. 6 . Plasma endotoxin concentrations after CLP. Plasma was harvested at 36 h after CLP. Endotoxin concentrations were measured using the limulus amoebocyte lysate assay. Values represent means Ϯ SE; n ϭ 5-7 mice/group. the full length of the cecum resulted in severe injury and mortality within 48 h after CLP in wild-type mice. This finding supports the contention that cecal ischemia is an important mechanism of injury after CLP. The blood supply to the rodent cecum arises primarily from the cranial mesenteric artery and runs from the base of the cecum to the apex (8) . Therefore, ligation of the cecum at its base will disrupt blood flow to areas distal to the ligation site, resulting in tissue ischemia. The functional importance of cecal ischemia in CLP-induced morbidity and mortality is supported by the studies of Singleton and Wischmeyer (21) , in which the length of cecum ligated, rather than puncture size, was the major predictor of inflammation and mortality in rats after CLP. Other studies have shown that resection of the ischemic cecum will reverse CLPinduced mortality (16) . Whether CD8 ϩ T and NK cells mediate ischemia-induced injury after CLP remains to be fully established. However, studies have shown that T cells participate in ischemia-associated injury in a variety of tissues. Granger and colleagues (6, 20) showed that CD8 ϩ T cells modulate local inflammation and facilitate vascular permeability within hours after intestinal ischemia-reperfusion injury. Rabb and coworkers (1, 35) showed that T cell depletion provides protection from ischemia-induced renal injury. CD4 ϩ and CD8 ϩ T cells have also been shown to facilitate innate mechanisms of neutrophil recruitment and endothelial injury during ischemic injury of the kidneys (3, 7, 36) . Further studies will be required to fully elucidate the cellular interactions that potentiate systemic injury during gut ischemia.
Another important consideration in the pathogenesis of inflammation caused by gut ischemia is interaction of T and NK cells with bacterial toxins such as endotoxin and bacterial superantigens that may disseminate after cecal injury. Gut ischemia can lead to deterioration of mucosal integrity with subsequent translocation of bacterial products in the systemic circulation (9, 24) . In the CLP model, there is also direct spillage of bacteria and their by-products into the peritoneal cavity. It has been postulated that endotoxin translocation is a major stimulus for postischemic inflammation. Some reports showed a clear correlation between plasma endotoxin concentrations, lactate production, and proinflammatory cytokine re- Values represent means Ϯ SE; n ϭ 6 -9 mice/group. *Significantly (P Ͻ 0.05) less than saline-treated ␤2MKO/␣AsGM1 mice. lease in models of postburn and hemorrhagic shock (22) . NK cells are known to facilitate endotoxin-induced shock by producing interferon (IFN)-␥ (31). NK cell-depleted mice exhibit an attenuated inflammatory response and decreased plasma IFN␥ concentrations after endotoxin challenge and are resistant to endotoxin-induced mortality (4, 13) . Other investigators have postulated that bacterial superantigens play a role in stimulating local and systemic inflammation associated with gut injury (11, 12) . Bacterial superantigens such as toxic shock syndrome toxin and staphylococcal enterotoxins stimulate an inflammatory response that is mediated primarily by T cells (10). As described above, we have reported that combined NK and T cell depletion provides a level of survival benefit after CLP that is greater than depletion of either cell type individually (18, 19) . This finding suggests that both cell types become activated after CLP to mediate or facilitate a lethal inflammatory response. The mechanisms of T and NK cell activation remain to be fully elucidated. However, translocation of both endotoxin and bacterial superantigens may be important factors causing T and NK cell activation after CLP. In the present study, endotoxin concentrations in blood and peritoneal fluid were not altered by imipenem treatment despite a marked decrease in bacterial counts. Further studies must be performed to establish the importance of microbial products as a stimulus for CD8
ϩ T and NK cell-mediated inflammation after CLP.
Results of the present study show that CLP-induced mortality correlates with hypothermia, metabolic acidosis, and increased production of proinflammatory cytokines and chemokines. These findings confirm and extend our previous findings on temperature regulation, acid-base balance, and cytokine production in wild-type and ␤2MKO/␣AsGM1 mice after CLP. Hypothermia and severe metabolic acidosis are predictors of mortality in mice after CLP (18, 19) . Metabolic acidosis is a surrogate marker of tissue hypoperfusion and is commonly seen during gut ischemia and in shock states (22) . The presence of severe metabolic acidosis indicates that a state of tissue hypoperfusion exists in wild-type mice after CLP. This is consistent with our previous reports showing that the ultimate mechanism of mortality in wild-type mice after CLP is cardiovascular collapse and shock (25) (26) (27) . Treatment of wild-type mice with imipenem did not improve CLP-induced hypothermia and metabolic acidosis, which indicates that systemic infection is not the underlying cause of these alterations. Our studies on cytokine production showed that IL-6, MIP-2, and KC were significantly lower in ␤2MKO/␣AsGM1 mice compared with wild-type controls. MIP-2 and KC were measured because a previous study by Heuer et al. (5) showed that increased concentrations of these chemokines are one of the best predictors of mortality in rodents after CLP. Several studies have shown a strong correlation between IL-6 production and CLP-induced mortality (16, 28) . Our previous studies have shown IL-6, MIP-2, and KC to be accurate markers of ultimate mortality in mice after CLP (18, 19) . The present study confirms that these cytokines and chemokines are accurate markers of mortality in mice exposed to CLP. These observations also indicate that inflammation is a major factor contributing to CLP-induced morbidity and mortality. Interestingly, treatment of wild-type mice with imipenem did not significantly decrease cytokine production. This finding indicates that local and systemic infection are not the major factors contributing to inflammation in the first 48 h after CLP and provides further evidence that infection is not an important cause of morbidity and mortality in our model of CLP.
In conclusion, the present study shows that treatment of ␤2MKO/␣AsGM1, but not wild-type C57BL/6J, mice with imipenem improves survival after CLP. This improved outcome was associated with attenuation of hypothermia, metabolic acidosis, and systemic inflammation. These findings indicate that infection is not the major cause of inflammation, morbidity, and mortality in wild-type mice after CLP. Noninfection-related causes of injury, such as cecal ischemia or translocation of bacterial toxins, may be important. Furthermore, ␤2MKO/␣AsGM1 mice appear resistant to these noninfectious mechanisms of CLP-induced injury but exhibit delayed mortality associated with bacterial dissemination. The latter mechanism of injury was greatly attenuated by treatment of ␤2MKO/␣AsGM1 mice with imipenem.
